BDH Industries
374.65
-0.90(-0.24%)
Market Cap₹215.78 Cr
PE Ratio20.75
IndustryHealthcare
Company Performance:
1D-0.24%
1M-0.29%
6M-13.72%
1Y+35.25%
5Y+280.36%
View Company Insightsright
More news about BDH Industries
08Aug 25
BDH Industries Approves Q1 FY 2025-26 Financial Results and Holds 35th AGM
BDH Industries' Board of Directors approved Q1 FY 2025-26 unaudited financial results on August 8, 2025. The company held its 35th Annual General Meeting via video conferencing, with 40 shareholders participating. Key AGM proceedings included adopting financial statements, declaring dividends, and re-appointing directors. Ms. Jayashree Nair was re-appointed as Managing Director, and Mr. S. C. Kachhara was re-designated and re-appointed as Managing Director. The company provided e-voting facilities for shareholders and committed to publishing financial results in newspapers as per SEBI regulations.
 no imag found
BDH Industries
374.65
-0.90
(-0.24%)
1 Year Returns:+35.25%
Industry Peers
Sun Pharmaceutical
1,620.40
(-3.55%)
Divis Laboratories
6,361.50
(-0.27%)
Torrent Pharmaceuticals
4,117.20
(-0.72%)
Dr Reddys Laboratories
1,317.10
(-1.04%)
Lupin
2,296.10
(-1.93%)
Cipla
1,295.00
(-0.83%)
Mankind Pharma
2,267.40
(-1.11%)
Zydus Life Science
927.40
(-2.00%)
Aurobindo Pharma
1,413.80
(-1.50%)
Glenmark Pharmaceuticals
2,299.50
(-1.52%)